Will New Restrictions on Plasma Donations at the Border Lead to IG Shortages?

By Gina Shaw
For well over a year, pharmacists, physicians and patients have been anticipating the possibility of a shortage of immune globulin (IG) products, as the COVID-19 pandemic led to a significant decline in donations of the blood plasma that is the primary component of these therapies.